Pro-inflammatory protein Cyclooxygenase-2 is upregulated and constitutionally expressed in GBM and is associated with increased aggressiveness, worse survival, and higher grade malignancies through immune evasion and consequent immunotherapy resistance within GBM (105–107). This evidence concerns the gene PTGS2 and glioblastoma.